Skip to content
POM-V Prescription Required Companion Animal

Fentadon 50 Microgram/ml, Solution for Injection/Infusion for Dogs

Active ingredient: Fentanyl

Form

Injection

Species

Dogs

Manufacturer

Eurovet Animal Health B.V.

VMD MA No.

16849/5014

What it's used for

For the control of post-operative pain associated with major orthopaedic and soft tissue surgery. AN: 03876/2023 and 03877/2023

Full indications, dosage and side effects ↓
View official SPC (PDF)

The prescription itself has a price. See what practices near you charge for a consultation and the written prescription fee.

Paying less for Fentanyl

  1. 1

    Ask your vet for a written prescription

    They must provide one on request. Under the CMA Order the fee is capped at £21 from 2027.

  2. 2

    Fill it at a registered online retailer

    The CMA found online pharmacies 50–60% cheaper than practice dispensing on common medicines — typically £200–£300 a year.

Prescription required

Your vet must provide a written prescription on request. You can then purchase from any licensed online retailer.

Clinical information

Fentadon 50 Microgram/ml, Solution for Injection/Infusion for Dogs — SPC Details

Source: VMD Summary of Product Characteristics (SPC). Last updated 27 Mar 2026.

For the control of post-operative pain associated with major orthopaedic and soft
tissue surgery.
AN: 03876/2023 and 03877/2023
To ensure a correct dosage, body weight should be determined as accurately as
possible. Onset of action is seen within 5 minutes. The duration of the analgesic
effect is 20 (lowest recommended dose) to 40 minutes (highest recommended dose).
Fentanyl can be administered according to the following dosage regimen:
Analgesia by Continuous Rate Infusion (CRI)
• 5 – 10 µg/kg (0.1 - 0.2 ml/kg) IV as a bolus, followed by 12 – 24 µg/kg/hr (0.24
- 0.48 ml/kg/hr) IV for intra-operative analgesia as CRI.
• 6 – 10 µg/kg/hr (0.12 - 0.2 ml/kg/hr) IV for subsequent post-operative
analgesia as CRI in sedated animals. During post-operative CRI administration of
fentanyl, animals should be monitored carefully.
AN: 03876/2023 and 03877/2023
Chemical-physical compatibility has only been demonstrated for dilutions 1:5 with the
following solutions for infusion: sodium chloride 0.9%, Ringer’s solution and glucose
5%.
The veterinary medicinal product has a narrow margin of safety and it is important to
measure the dose accurately to avoid overdosing.
Do not use in cases of hypersensitivity to the active substance, or to any of the
excipients.
Do not use in dogs with cardiac failure, hypotension, hypovolaemia, obstructive
airway disease, respiratory depression, hypertension or with a history of epilepsy.
Do not use in animals with severe liver or renal dysfunction.
Refer to sections 3.7 and 3.8.
Dogs:
Very common
(>1 animal / 10 animals
treated):
Hyperactivity, Irritability, Vocalisation
Involuntary defecation, Tongue protrusion,
Vomiting
Tremor
a
, Sedation
Urination
Increased respiratory rate, Panting
Scratching
Common
(1 to 10 animals / 100 animals
treated):
Respiratory depression
b

Bradycardia
c
, Hypotension
d
Uncommon
(1 to 10 animals / 1,000 animals
treated):
HypothermiaRare
(1 to 10 animals / 10,000
animals treated):
Lowered nociceptive thresholds
e
AN: 03876/2023 and 03877/2023
a Tremors of the body.
b Can be of long duration and may exhibit a biphasic pattern.
c Due to increased cardiac vagal stimulation.
d Transient. Following intravenous administration of fentanyl citrate even at doses of
2.5 – 5 μg/kg.
e When the effects of the drug dissipate.
Reporting adverse events is important. It allows continuous safety monitoring of a
veterinary medicinal product. Reports should be sent, preferably via a veterinarian, to
either the marketing authorisation holder or its local representative or the national
competent authority via the national reporting system. See the package leaflet for
respective contact details.
The use of this veterinary medicinal product must be preceded by a thorough clinical
examination. Atropine may be used to block the vagal effects.
This veterinary medicinal product should be titrated for the individual animal to an
effective dose that provides adequate analgesia and minimises undesirable effects.
Animals should be carefully monitored until an effective dose is reached. Due to
individual differences in pain sensitivity, the effects of fentanyl may be variable. Older
animals may tend to titrate to a lower effective dose than younger animals.
It is important when estimating the required dose for intra-operative analgesia to
assess the likely degree of surgical stimulation, the effect of premedication drugs,
whether supportive care like endotracheal intubation and ventilatory support may be
required, and the duration of the procedure.
If other narcotic or CNS-depressant drugs (e.g. propofol, isoflurane, sevoflurane) are
used concurrently with fentanyl the doses of these agents may need to be reduced.
When estimating the required dose for post-operative analgesia the degree of tissue
damage has to be assessed.

Special precautions for safe use in the target species:
If other narcotic or CNS-depressant drugs (e.g. propofol, isoflurane, sevoflurane) are
used concurrently with fentanyl the doses of these agents may need to be reduced.
As a class, opioids, including this veterinary medicinal product, may cause
hypothermia with duration related to dose, bradypnea, hypotension and bradycardia.
Therefore, animals should be continuously monitored for rectal temperature, pulse
rate, respiratory rate and heart rhythm during surgical anaesthesia.
In case of renal, cardiac or hepatic dysfunction, hypovolaemia or shock, there may be
greater risk associated with the use of the product. It is desirable to reduce dosage in
case of hypothyroidism and in case of chronic hepatic or renal disease. As with all
narcotic analgesics, care should be taken when administering fentanyl to animals
with myasthenia gravis.
Facilities for the maintenance of a patent airway, intermittent positive pressure
ventilation (IPPV) and oxygen supplementation should be available. When respiratory
depression occurs, controlled ventilation should be installed.
As with all potent opioids, profound analgesia is accompanied by respiratory
depression, which may persist into or recur in the early post-operative period. The
respiratory depressant effects may be more problematic in animals with pre-existing
respiratory disease or increased intracranial pressure. The effect of an opioid on
head injury is dependent on the type and severity of the injury and the respiratory
support supplied. It is imperative to ensure that adequate spontaneous breathing has
AN: 03876/2023 and 03877/2023
been established and maintained before discharge from the recovery area whenever
large doses of infusions of fentanyl have been administered. The benefit/risk ratio for
using the veterinary medicinal product should be made by the attending vet. The
pharmacological effects of fentanyl citrate can be reversed by naloxone.
Special precautions to be taken by the person administering the veterinary medicinal
product to animals
Fentanyl, an opioid, may cause adverse effects after internal exposure, including
respiratory depression or apnoea, sedation, hypotension and coma.
The veterinary medicinal product may cause hypersensitivity reactions. Avoid contact
with the skin and eyes. Personal protective equipment consisting of protective gloves
should be worn when handling the veterinary medicinal product. Wash hands after
use. Wash any splashes from skin and eyes immediately with large amounts of
water. Remove contaminated clothes.
Care should be taken to avoid accidental self-injection. In case of accidental self-
injection, seek medical advice immediately and show the package leaflet to the
doctor but DO NOT DRIVE as sedation may occur.
Adverse effects on the foetus cannot be excluded. Pregnant women should avoid
handling the veterinary medicinal product. In case of women who are breastfeeding
being accidentally exposed, breastfeeding is discouraged for 24 hours, as fentanyl
may transfer to breast milk.
To the physician:
Fentanyl is an opioid whose toxicity may cause clinical effects, including respiratory
depression or apnoea, sedation, hypotension and coma. When respiratory
depression occurs, controlled ventilation should be installed. Administration of the
opioid antagonist naloxone to reverse the symptoms is recommended.
Special precautions for the protection of the environment:
Not applicable.
Fentanyl is a potent anaesthetic sparing substance. To avoid anaesthetic overdose in
dogs treated with the veterinary medicinal product, anaesthetic agents should be
administered only until the desired effect is produced.
The veterinary medicinal product should be used with caution in conjunction with
morphine or other opioid type analgesics as the effects have not been studied.
The effects of the concomitant use of the veterinary medicinal product and α-
adrenergic agonists have not been studied. Therefore, α2-adrenergic
be used with caution in animals dosed with the veterinary medicinal product due to
potentially additive or synergistic effects.
Do not freeze.
Not applicable

This information is sourced from the official Summary of Product Characteristics (SPC) published by the Veterinary Medicines Directorate (VMD). It is provided for informational purposes only and does not replace professional veterinary advice. Always consult your vet before administering any medication.

Medication costs adding up?

Pet insurance can cover prescription medications. Find the right policy for your pet.

Compare insurance
Same active ingredient

Other Products Containing Fentanyl

These products share the same active ingredient and may be suitable alternatives. Always consult your vet.

Find cheaper vets near you

Compare vet consultation prices in your area. Save on procedures and get a prescription to buy medications online.